SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARCHETTI, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.798
AS - Asia 7.608
EU - Europa 4.227
SA - Sud America 1.194
Continente sconosciuto - Info sul continente non disponibili 215
AF - Africa 168
OC - Oceania 15
Totale 29.225
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.404
SG - Singapore 2.775
CN - Cina 1.955
BR - Brasile 919
VN - Vietnam 901
DE - Germania 893
UA - Ucraina 757
IT - Italia 696
HK - Hong Kong 619
TR - Turchia 459
GB - Regno Unito 423
SE - Svezia 265
FI - Finlandia 252
FR - Francia 240
RU - Federazione Russa 214
CA - Canada 196
JP - Giappone 188
BD - Bangladesh 186
PL - Polonia 159
IN - India 141
MX - Messico 126
AR - Argentina 90
ID - Indonesia 77
NL - Olanda 68
ZA - Sudafrica 62
IQ - Iraq 53
EC - Ecuador 51
BE - Belgio 48
ES - Italia 47
CO - Colombia 40
PK - Pakistan 39
CZ - Repubblica Ceca 34
MA - Marocco 30
UZ - Uzbekistan 30
VE - Venezuela 29
LT - Lituania 23
MY - Malesia 23
CL - Cile 22
PH - Filippine 22
SA - Arabia Saudita 22
PY - Paraguay 20
KE - Kenya 18
IE - Irlanda 17
CR - Costa Rica 16
AT - Austria 15
JM - Giamaica 15
TN - Tunisia 15
NP - Nepal 13
AU - Australia 12
IR - Iran 12
JO - Giordania 12
UY - Uruguay 12
AE - Emirati Arabi Uniti 11
PT - Portogallo 11
TW - Taiwan 11
IL - Israele 10
PE - Perù 9
TT - Trinidad e Tobago 9
EG - Egitto 8
RO - Romania 8
CH - Svizzera 7
DZ - Algeria 7
AL - Albania 6
AZ - Azerbaigian 6
GT - Guatemala 6
KZ - Kazakistan 6
PS - Palestinian Territory 6
ET - Etiopia 5
OM - Oman 5
RS - Serbia 5
SN - Senegal 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
EU - Europa 4
GR - Grecia 4
LV - Lettonia 4
PA - Panama 4
PR - Porto Rico 4
SV - El Salvador 4
TH - Thailandia 4
DO - Repubblica Dominicana 3
EE - Estonia 3
HU - Ungheria 3
LB - Libano 3
MT - Malta 3
NG - Nigeria 3
NI - Nicaragua 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BW - Botswana 2
BY - Bielorussia 2
HN - Honduras 2
KG - Kirghizistan 2
KH - Cambogia 2
KR - Corea 2
KW - Kuwait 2
LK - Sri Lanka 2
Totale 28.982
Salva come PNG Salva come JPEG
Città #
Singapore 1.717
Ashburn 1.517
San Jose 1.155
Fairfield 1.044
Woodbridge 1.044
Chandler 780
Jacksonville 777
Houston 775
Santa Clara 658
Ann Arbor 623
Hong Kong 603
Beijing 575
Council Bluffs 469
Seattle 444
Wilmington 411
Cambridge 378
Dallas 374
Ho Chi Minh City 293
Izmir 259
New York 247
Nanjing 244
Los Angeles 236
Munich 218
Hanoi 213
Tokyo 181
Boardman 180
Princeton 171
Warsaw 150
Lauterbourg 143
The Dalles 139
Ferrara 136
San Diego 112
Milan 111
Buffalo 97
São Paulo 97
Mexico City 88
Shanghai 84
Orem 79
Nanchang 70
Shenyang 69
Toronto 65
Dearborn 63
Bremen 62
Tianjin 62
London 61
Hebei 57
Helsinki 57
Turku 54
Hefei 52
Phoenix 49
Montreal 48
Rome 48
Chicago 46
Frankfurt am Main 46
Brussels 45
Düsseldorf 45
San Mateo 45
Jakarta 44
Jiaxing 44
Changsha 43
Brooklyn 41
Chennai 40
Falkenstein 38
Falls Church 38
Da Nang 37
Haiphong 36
Jinan 34
Denver 33
Johannesburg 33
Moscow 33
Amsterdam 31
Kunming 31
San Francisco 30
Norwalk 29
Rio de Janeiro 29
Addison 28
Atlanta 28
Redwood City 28
Tashkent 28
Boston 27
Brno 27
Manchester 27
Belo Horizonte 26
Guangzhou 24
Stockholm 24
Baghdad 23
Auburn Hills 22
Florence 22
Philadelphia 22
Des Moines 21
Nuremberg 21
Zhengzhou 20
Biên Hòa 19
Columbus 19
Mountain View 19
Washington 19
Curitiba 18
Hải Dương 18
Naples 18
Mumbai 17
Totale 19.075
Salva come PNG Salva come JPEG
Nome #
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 380
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 335
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 322
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 272
Hemostasis biomarkers in multiple sclerosis 271
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 271
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 270
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 269
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 268
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 263
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 263
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 261
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 260
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 254
Membrane binding and anticoagulant properties of protein S natural variants 252
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 251
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 245
c-myc oncogene alterations in human thyroid carcinomas. 239
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 234
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 233
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 230
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 230
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 228
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 227
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 225
Calmodulin Is a Marker of a Distinct Smooth Muscle Cell Population Recruited by Plaque-Derived Macrophages from the Human Carotid Artery Media 224
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 220
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 219
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala(223)Val MTHFR) in patients with inherited thrombophilic coagulation defects 216
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 214
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 213
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 213
Organization of α-Globin Genes and mRNA Translation in Subjects Carrying Haemoglobin Hasharon (α47 Asp → His) from the Ferrara Region (Northern Italy) 212
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 212
Plasma levels of soluble NCAM in multiple sclerosis 212
Factor VII mutant V154G models a zymogen-like form of factor VIIa 209
A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide 209
Characterization of PAR-mediated signaling induced by activated coagulation factor X mutants 209
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 209
Interaction of occupational posture, lifestyle and genetic components of thrombophilia 208
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 207
A RECURRENT AMINOACID SUBSTITUTION AND A PARTIAL GENE DELETION IN SEVERE HEMOPHILIA A 205
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 204
Partial gene deletion in a family with factor X deficiency 203
CHARACTERIZATION OF THE PSEUDOGENIC REGION OF VON WILLEBRAND FACTOR BY MOLECULAR CLONING AND "IN SITU" HYBRIDIZATION 201
alpha-Thalassemia trait in the region of Ferrara. 201
Modulation of factor VII levels by intron 7 polymorphisms: Population and in vitro studies 198
Molecular mechanisms of FVII deficiency: Expression of mutations clustered in the IVS7 donor splice site of factor VII gene 195
Characterization of the intracellular signalling capacity of natural FXa mutants with reduced pro-coagulant activity 194
Human leukemia K562 cells: Relationship between hemin-mediated erythroid induction, cell proliferation and expression of c-abl and c-myc oncogenes 193
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors 193
How to evaluate phenotype-genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency 190
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 189
Rapid detection of a protein C gene mutation present in the asymptomatic and not in the thrombosis‐prone lineage 189
Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme 189
Characterization and mapping of the 5′ portion of von Willebrand factor pseudogene 188
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 186
Molecular genetics and biology of congenital hemorrhagic diseases 186
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques? 184
Taqi polymorphism at the human coagulation factor XII locus (F12) 184
Angiotensin-converting enzyme gene polymorphism made risk of restenosis after coronary stenting 184
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 182
CHROMOSOMAL LOCALIZATION AND CHARACTERIZATION OF RFLPs IN THE VON WILLEBRAND FACTOR PSEUDOGENE 181
Detection and characterization of polymorphic markers in the factor-VII gene. 180
A HIND III RFLP AND A GENE LESION IN THE COAGULATION FACTOR-VIII GENE 179
PRIMARY INTRAVASCULAR SYNOVIAL SARCOMA OF THE FEMORAL VEIN IN A MALE PATIENT, CASE REPORT 178
Localization of cloned human DNA sequences and analysis of chromosomal alteration by in situ hybridization 178
Two taqI RFLPs in the human von willebrand factor gene 178
In-Frame Deletion of von Willebrand Factor Exons 26-34 (D3-A3 Domains) in Type II von Willebrand Disease. 177
Impaired prothrombinase activity of factor X Gly381 Asp results in severe familial CRM+ FX deficiency 176
Symptomatic type II protein C deficiency caused by a missense mutation (Gly 381-->Ser) in the substrate-binding pocket 175
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 175
Baseline and overtime variations of soluble adhesion molecule plasma concentrations are associated with mobility recovery after rehabilitation in multiple sclerosis patients 175
Alterazione genica "de novo" in una variante della malattia di von Willebrand. 174
Factor V markers for the detection of genetic components of APC resistance in venous thrombosis 174
New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V leiden mutation in Mediterranean populations and Indians 173
The Gly331Ser mutation in factor VII in Europe and the Middle East 171
Two additional TaqI RFLPs in von willebrand factor gene (VWF) and pseudogene 171
Hemostasis gene expression of the internal jugular and saphenous veins 170
Caratterizzazione di una nuova mutazione nell’esone 28 del gene del fattore di von Willebrand (FvW) responsabile della malattia di vW di tipo IIA. 168
Sublocalization of von Willebrand Factor Pseudogene in 22q11.22-q11.23 and Detection of two TaqI RFLPs. 166
Modulation of FVII levels by intron 7 polymorphisms: population and in vitro studies 165
Hyperhomocysteinemia and a common methylene-tetrahydrofolate reductase mutation (Ala223Val MTHFR) are not associated with a history of thrombosis in patients with inherited thrombophilia 165
A FREQUENT FACTOR-XII GENE MUTATION IN HAGEMAN TRAIT 165
Study of a G/A variation in the 3' untranslated region of prothrombin mRNA in Italian patients with venous thrombosis 163
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients 163
Decay of β-globin synthesis in heterozygous β 0 Ferrara thalassaemia 162
Factor V markers for the detection of genetic components of APC resi stance in venous thrombosis. 162
Soluble neural cell adhesion molecule and behavioural recovery in minimally conscious patients undergoing transcranial direct current stimulation 162
Identification of a c-myc oncogene lacking the exon 1 in the normal cells of a patient carrying a thyroid carcinoma 161
CCL18 plasma levels are increased in progressive MS patients and associated with MRI outcomes of tissue injury (P1.396) 161
Non-conventional therapeutic strategies for inherited disorders of hemostasis 160
Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7) 160
Contribution of asialoglycoprotein receptor ASGR2 5’ UTR polymorphisms to full-length FVIII concentrate pharmacokinetics 158
The Asialoglycoprotein Receptor Minor Subunit Gene Contributes to Pharmacokinetics of Factor VIII Concentrates in Hemophilia A 158
Combination of Genomic and Transcriptomic Approaches Highlights Vascular and Circadian Clock Components in Multiple Sclerosis 157
Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency 157
Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis 157
Clinical picture and management of congenital factor VII deficiency 156
Risks factors for highly unstable response to oral anticoagulation: a case-control study 156
Totale 20.364
Salva come PNG Salva come JPEG
Categoria #
all - tutte 131.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.200
Totale 132.263
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.390 0 0 0 111 114 64 73 80 53 129 153 613
2022/20231.766 189 123 45 215 282 289 74 165 221 14 91 58
2023/2024924 69 91 34 32 64 191 20 62 23 20 24 294
2024/20253.496 93 66 295 99 468 299 78 173 507 479 536 403
2025/202610.288 974 410 1.066 1.331 1.495 707 1.306 507 941 966 367 218
2026/20272.126 241 576 1.045 264 0 0 0 0 0 0 0 0
Totale 29.225